AzTrials
AzTrials

HerniorrhaphyNCT02302222

The Management of Closed Surgical Incisions Resulting From Incisional Hernia Repair and/or Functional Panniculectomy Using the Prevena™ Customizable™ Dressing

A study testing Customizable Dressing with ActiV.A.C. Therapy Unit in people with Herniorrhaphy and Abdominoplasty, run by KCI USA, Inc at 2 sites in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The goal of this study is to evaluate the impact of Customizable in the management of extensive closed surgical incisions for Subjects undergoing abdominal surgery for incisional hernia repair and/or functional panniculectomy as compared to SOC dressing, and to significantly reduce the SSC rate experienced by Subjects… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Herniorrhaphy, Abdominoplasty
What is being tested?
Customizable Dressing with ActiV.A.C. Therapy Unit
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
71 participants
Where
2 sitesUnited States
Study dates
May 2015to 31 Jul 2017
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Pre-Operative Inclusion Criteria:

  1. an adult 18 years old or older of either gender
  2. able to provide their own informed consent
  3. will undergo:
  4. a functional panniculectomy with a transverse or a fleur-de-lis incision
  • AND/OR -
  1. an incisional hernia repair with a vertical incision at least 20 cm in length and at least 10 cm of undermining on each side of the incision
  2. BMI equal to or greater than 30
  3. has maintained a stable weight for at least 3 months as determined by the Investigator (applies to post weight loss patients only)
  4. pre-operatively assessed to undergo a procedure with a CDC Wound Classification of:
  5. Class I (Clean): An uninfected operative wound in which no inflammation is encountered and the respiratory, alimentary, genital or uninfected urinary tract is not entered
  • OR -
  1. Class II (Clean Contaminated): An operative wound in which the respiratory, alimentary, genital or uninfected urinary tract are entered under controlled conditions and without unusual contamination
  2. willing and able to return for all scheduled study visits
  3. if a female of child-bearing potential, must test negative on a urine pregnancy test
  4. if a female of child-bearing potential, must be willing to utilize an acceptable method of birth control (i.e. oral contraceptives, condom with spermicide, diaphragm with spermicide, implants, IUD, injections, vaginal rings, hormonal skin patch) for the duration of the study

Intra-Operative Inclusion Criteria:

  1. continues to meet all pre-operative inclusion criteria
  2. has undergone a Class I or II CDC Wound Classification procedure resulting in a closed surgical incision able to be covered completely by Customizable dressing

Pre-Operative Exclusion Criteria:

  1. has a systemic bacterial or fungal infection at the time of surgery for incisional hernia repair and/or functional panniculectomy
  2. has a remote-site skin infection at the time of surgery for incisional hernia repair or functional panniculectomy
  3. pre-operatively assessed to undergo a procedure with a CDC Wound Classification of:
  4. Class III (Contaminated): Open, fresh, accidental wounds, and/or major breaks in sterile technique or gross spillage from the gastrointestinal tract
  • OR -
  1. Class IV (Dirty-Infected): Old traumatic wounds with retained devitalized tissue and those that involve existing clinical infection or perforated viscera
  2. will have a transverse or fleur-de-lis incision that extends beyond the flank area and requires moving the Subject from the supine position during surgery
  3. has a known allergy or hypersensitivity to silver, or drape materials that contain acrylic adhesives
  4. has participated in a clinical study within the past 30 days
  5. who, in the investigator's opinion, would have any clinically significant condition that would impair the Subject's ability to comply with the study procedures

Post-Operative Exclusion Criteria:

  1. found to meet any of the pre-operative exclusion criteria
  2. determined to have a CDC Wound Classification of:
  3. Class III (Contaminated): Open, fresh, accidental wounds, and/or major breaks in sterile technique or gross spillage from the gastrointestinal tract
  • OR -
  1. Class IV (Dirty-Infected): Old traumatic wounds with retained devitalized tissue and those that involve existing clinical infection or perforated viscera

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Medical Research Center

    Miami, Florida, 33144

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania, 15213

Other trials in United States

About this study

The goal of this study is to evaluate the impact of Customizable in the management of extensive closed surgical incisions for Subjects undergoing abdominal surgery for incisional hernia repair and/or functional panniculectomy as compared to SOC dressing, and to significantly reduce the SSC rate experienced by Subjects receiving Customizable vs. SOC surgical incision dressing.

Being tested
Customizable Dressing with ActiV.A.C. Therapy Unit, Standard of Care Dressing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Customizable Dressing with ActiV.A.C. Therapy UnitDevice

  • Standard of Care DressingDevice

Study groups in NCT02302222
Study groupRoleWhat they receive
Standard of CareActive comparatordry sterile dressing/gauze and steristrips
Receives: Device: Standard of Care Dressing
CustomizableExperimentalPrevena Customizable Dressing with ActiV.A.C. Therapy Unit
Receives: Device: Customizable Dressing with ActiV.A.C. Therapy Unit

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Participants With Surgical Site Complications

    Surgical Site Complications:

    • Dehiscence
    • Surgical site infection (SSI)

    Measured: Within 30 Days Post-Surgical Procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Nov 2014 (estimated)
  2. Study startMay 2015
  3. Primary completion31 Jul 2017
  4. Study completion31 Jul 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
71 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02302222
Sponsor's protocol ID
AHS.2012.Customizable.01
Status last verified
Oct 2024
First submitted
24 Nov 2014
Last updated
16 Oct 2024
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Customizable Dressing with ActiV.A.C. Therapy Unit in people with Herniorrhaphy and Abdominoplasty, run by KCI USA, Inc at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 16 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 12 Dec 2018). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Participants With Surgical Site Complications (time frame: Within 30 Days Post-Surgical Procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in